PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study
Status:
Recruiting
Trial end date:
2022-02-02
Target enrollment:
Participant gender:
Summary
This pilot study will investigate the use of PSMA-PET/MRI (Positron Emission Tomography/
Magnetic Resonance Imaging)to guide radiation treatment planning in patients with known or
suspected locally metastatic prostate cancer at the time of diagnosis. Patients will undergo
a single PSMA-PET/MRI (or PET/CT (Computed Tomography) in some circumstances) prior to
initiation of treatment. Following development of a PSMA-PET guided radiation treatment plan,
therapeutic radiation will be delivered per standard-of-care parameters and assessments of
feasibility and tolerability will be performed.